Karen is an experienced intellectual property (IP) and commercialisation specialist with over 15 years’ experience supporting the translation of research into real-world healthcare solutions. Her expertise spans the full innovation lifecycle—from identifying and evaluating new technologies, through to securing IP protection, developing assets, and negotiating commercial deals.
Karen has successfully led licensing negotiations across a broad spectrum of technologies including therapeutics, medical devices and digital health products. Her career encompasses roles within technology transfer offices and, most recently, with a UK based biotech company working in the gene therapy field. There, she was instrumental in negotiating licensing and collaborative agreements including managing the term sheet creation process as well assisting with the identification of licensing and partnerships needs and opportunities. Karen also developed a company-wide data room and was involved in responding to investor due diligence questions in connection with Series C and IPO investments.
Karen holds a PhD in Analytical Chemistry and a BSc in Biochemistry from the University of Manchester. She joined HTE in 2021 and is passionate about supporting the development and commercialisation of early-stage healthcare innovations.
“I’m driven by the opportunity to help bring healthcare technology to market – especially those that have the potential to make a real difference to patients’ lives.”
